Patients with multiple myeloma often develop bone lesions resulting in skeletal-related events (SREs), such as spinal cord compression, vertebral collapse, pathologic fractures and bone pain. Bone ...

The aim of this retrospective investigation was to compare the diagnostic performance of a fully integrated whole-body PET/MRI scanner (Biograph mMR; Siemens Medical Solutions; Malvern, Pennsylvania) ...

The Independent Data Monitoring Committee recommended transitioning patients in the placebo arm to garetosmab as soon as possible. Topline data were announced from a phase 3 trial evaluating ...

A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a ...

For patients with mCRPC with bone metastases, the addition of radium-223 to enzalutamide therapy is associated with improved overall survival.

Patients with midfoot pain and MRI-detected bone marrow lesions who wore firm foot orthoses achieved greater reductions in pain and bone marrow lesion volume over 12 weeks than those who wore ...

The team tackled a critical challenge in treating multiple myeloma-a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients. These ...

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is one of the best value stocks to buy now. On February 19, Regeneron Pharmaceuticals announced that the FDA accepted its BLA for garetosmab for Priority ...

BEIJING -- A team of paleontologists has discovered the first-known evidence of a bone tumor in a vertebrate preserved in ...